Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome
Background. Rituximab is effective for treatment of children with refractory nephrotic syndrome (NS). However, the drug may cause serum sickness characterized by fever, rash, and arthralgia 10-14 days after primary antigen exposure or within a few
Meral Torun Bayram +2 more
doaj +1 more source
Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy [PDF]
Cheong J, Ooi K.
exaly +2 more sources
Perceived Motion Sickness and Effects on Performance Following Naval Transportation [PDF]
The present study focused on the relationship between previous experiences of, and rated susceptibility to, motion sickness and its correlation to subjective measurements and actual performance.
Fredrik Forsman +10 more
core +1 more source
Clinical and biochemical response of treatment with anti-TNFα in Egyptian IBD patients: Zagazig University IBD Clinic experience [PDF]
The aim is to evaluate the clinical and biochemical response of treatment with anti-tumor necrosis factorα (anti-TNFα) therapy used for induction and maintenance of remission in Egyptian inflammatory bowel disease (IBD) patients who attended an IBD ...
Afify Afify +3 more
doaj +1 more source
Antivenin-related Serum Sickness [PDF]
Serum sickness is a type III hypersensitivity reaction that occurs due to the deposition of excessive circulating immune complexes in patients treated with foreign proteins or haptens.
Chen, Wei-Kung +5 more
core +1 more source
A powerful intervention: general practitioners' use of sickness certification in depression [PDF]
<b>Background</b> Depression is frequently cited as the reason for sickness absence, and it is estimated that sickness certificates are issued in one third of consultations for depression. Previous research has considered GP views of sickness
Whittaker, Will +39 more
core +2 more sources
Reacción similar a la enfermedad del suero secundaria al uso de cefalotina: reporte de un caso
Serum sickness (SS) and SS-like reactions (SSLR) are indistinguishable clinical entities but with different pathophysiological processes, particularly regarding its impact on the complement system.
Germán Sepúlveda-Barbosa
doaj +1 more source
Rituximab Hypersensitivity: From Clinical Presentation to Management
Rituximab is a chimeric monoclonal antibody (mAb) against CD20 molecule which is expressed on human B cells. It has been used for the treatment of various lymphoid malignancies, lymphoproliferative diseases, and rheumatologic disorders.
Ghada E. Fouda, Sevim Bavbek
doaj +1 more source
Firms’ moral hazard in sickness absences [PDF]
Sick workers in many countries receive sick pay during their illness- related absences from the workplace. In several countries, the social security system insures firms against their workers’ sickness absences.
René Böheim, Thomas Leoni
core +4 more sources
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source

